The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...

The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...

In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of Ozempic and Wegovy — notified the agency that “several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg ...

Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who ...

HHS Secretary Robert F. Kennedy Jr.’s sweeping layoffs across federal health agencies are disrupting the work of drug, ...